These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 33851448)

  • 1. The effects of nano-curcumin supplementation on glycemic control, blood pressure, lipid profile, and insulin resistance in patients with the metabolic syndrome: A randomized, double-blind clinical trial.
    Bateni Z; Rahimi HR; Hedayati M; Afsharian S; Goudarzi R; Sohrab G
    Phytother Res; 2021 Jul; 35(7):3945-3953. PubMed ID: 33851448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of curcumin supplementation on glycemic status, lipid profile and hs-CRP levels in overweight/obese women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled clinical trial.
    Sohaei S; Amani R; Tarrahi MJ; Ghasemi-Tehrani H
    Complement Ther Med; 2019 Dec; 47():102201. PubMed ID: 31780025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of green coffee extract supplementation on anthropometric indices, glycaemic control, blood pressure, lipid profile, insulin resistance and appetite in patients with the metabolic syndrome: a randomised clinical trial.
    Roshan H; Nikpayam O; Sedaghat M; Sohrab G
    Br J Nutr; 2018 Feb; 119(3):250-258. PubMed ID: 29307310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of concentrated beetroot juice consumption on glycemic control, blood pressure, and lipid profile in type 2 diabetes patients: randomized clinical trial study.
    Karimzadeh L; Sohrab G; Hedayati M; Ebrahimof S; Emami G; Razavion T
    Ir J Med Sci; 2023 Jun; 192(3):1143-1153. PubMed ID: 35869311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of curcumin on body weight, glycemic control and serum lipids in women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial.
    Jamilian M; Foroozanfard F; Kavossian E; Aghadavod E; Shafabakhsh R; Hoseini A; Asemi Z
    Clin Nutr ESPEN; 2020 Apr; 36():128-133. PubMed ID: 32220355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of curcumin and high-content eicosapentaenoic acid supplementations in type 2 diabetes mellitus patients: a double-blinded randomized clinical trial.
    Asghari KM; Saleh P; Salekzamani Y; Dolatkhah N; Aghamohammadzadeh N; Hashemian M
    Nutr Diabetes; 2024 Apr; 14(1):14. PubMed ID: 38589346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sesame oil and vitamin E co-administration may improve cardiometabolic risk factors in patients with metabolic syndrome: a randomized clinical trial.
    Farajbakhsh A; Mazloomi SM; Mazidi M; Rezaie P; Akbarzadeh M; Ahmad SP; Ferns GA; Ofori-Asenso R; Babajafari S
    Eur J Clin Nutr; 2019 Oct; 73(10):1403-1411. PubMed ID: 31089253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of curcumin supplementation on metabolic parameters, inflammatory factors and obesity values in women with rheumatoid arthritis: A randomized, double-blind, placebo-controlled clinical trial.
    Pourhabibi-Zarandi F; Rafraf M; Zayeni H; Asghari-Jafarabadi M; Ebrahimi AA
    Phytother Res; 2022 Apr; 36(4):1797-1806. PubMed ID: 35178811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of curcumin and/or coenzyme Q10 supplementation on metabolic control in subjects with metabolic syndrome: a randomized clinical trial.
    Sangouni AA; Taghdir M; Mirahmadi J; Sepandi M; Parastouei K
    Nutr J; 2022 Oct; 21(1):62. PubMed ID: 36192751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nano-curcumin improves glucose indices, lipids, inflammation, and Nesfatin in overweight and obese patients with non-alcoholic fatty liver disease (NAFLD): a double-blind randomized placebo-controlled clinical trial.
    Jazayeri-Tehrani SA; Rezayat SM; Mansouri S; Qorbani M; Alavian SM; Daneshi-Maskooni M; Hosseinzadeh-Attar MJ
    Nutr Metab (Lond); 2019; 16():8. PubMed ID: 30705687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Curcumin on Glycemic Control and Lipid Profile in Polycystic Ovary Syndrome: Systematic Review with Meta-Analysis and Trial Sequential Analysis.
    Chien YJ; Chang CY; Wu MY; Chen CH; Horng YS; Wu HC
    Nutrients; 2021 Feb; 13(2):. PubMed ID: 33669954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Theobromine supplementation in combination with a low-calorie diet improves cardiovascular risk factors in overweight and obese subjects with metabolic syndrome: a randomized controlled trial.
    Sharifi-Zahabi E; Rezvani N; Hajizadeh-Sharafabad F; Hosseini-Baharanchi FS; Shidfar F; Rahimi M
    Food Funct; 2023 Sep; 14(18):8431-8441. PubMed ID: 37615657
    [No Abstract]   [Full Text] [Related]  

  • 13. The effects of taurine supplementation on glycemic control and serum lipid profile in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial.
    Maleki V; Alizadeh M; Esmaeili F; Mahdavi R
    Amino Acids; 2020 Jul; 52(6-7):905-914. PubMed ID: 32472292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of MK-7 Supplementation on Glycemic Status, Anthropometric Indices and Lipid Profile in Patients with Type 2 Diabetes: A Randomized Controlled Trial.
    Karamzad N; Faraji E; Adeli S; Carson-Chahhoud K; Azizi S; Pourghassem Gargari B
    Diabetes Metab Syndr Obes; 2020; 13():2239-2249. PubMed ID: 32617013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of curcumin supplementation on anthropometric indices, insulin resistance and oxidative stress in patients with type 2 diabetes: a randomized, double-blind clinical trial.
    Hodaei H; Adibian M; Nikpayam O; Hedayati M; Sohrab G
    Diabetol Metab Syndr; 2019; 11():41. PubMed ID: 31149032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of zinc supplementation on markers of insulin resistance and lipid profiles in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial.
    Foroozanfard F; Jamilian M; Jafari Z; Khassaf A; Hosseini A; Khorammian H; Asemi Z
    Exp Clin Endocrinol Diabetes; 2015 Apr; 123(4):215-20. PubMed ID: 25868059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of omega-3 fatty acid supplementation on insulin metabolism and lipid profiles in gestational diabetes: Randomized, double-blind, placebo-controlled trial.
    Samimi M; Jamilian M; Asemi Z; Esmaillzadeh A
    Clin Nutr; 2015 Jun; 34(3):388-93. PubMed ID: 24973862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of nano-curcumin on HbA1c, fasting blood glucose, and lipid profile in diabetic subjects: a randomized clinical trial.
    Rahimi HR; Mohammadpour AH; Dastani M; Jaafari MR; Abnous K; Ghayour Mobarhan M; Kazemi Oskuee R
    Avicenna J Phytomed; 2016; 6(5):567-577. PubMed ID: 27761427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of curcumin supplementation on high-sensitivity C-reactive protein, serum adiponectin, and lipid profile in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled trial.
    Adibian M; Hodaei H; Nikpayam O; Sohrab G; Hekmatdoost A; Hedayati M
    Phytother Res; 2019 May; 33(5):1374-1383. PubMed ID: 30864188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Effects of Curcumin on Glycemic Control and Lipid Profiles Among Patients with Metabolic Syndrome and Related Disorders: A Systematic Review and Metaanalysis of Randomized Controlled Trials.
    Tabrizi R; Vakili S; Lankarani KB; Akbari M; Mirhosseini N; Ghayour-Mobarhan M; Ferns G; Karamali F; Karamali M; Taghizadeh M; Kouchaki E; Asemi Z
    Curr Pharm Des; 2018; 24(27):3184-3199. PubMed ID: 30156145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.